JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, vol.11, no.7, pp.521-526, 2017 (SCI-Expanded)
Introduction: This study was initiated to investigate the risk factors of secondary infections in febrile neutropenic patients following chemotherapy, and to evaluate the clinical, microbiological, and mortality outcomes of these infections.